Detailansicht

Wissensnetz

Person

Thomas Seufferlein (1963-)

Arzt

Name	Thomas Seufferlein
Zeit	1963- (Lebensdaten)
Ort	Marktredwitz (Geburtsort) Ulm (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Thomas T. W. Seufferlein Thomas W. Seufferlein
Beziehung	Universitätsklinikum Ulm. Klinik für Innere Medizin I
Weitere Angaben	Ärztlicher Direktor der Klinik für Innere Medizin I, Universitätsklinikum Ulm
Datensatztyp	Person
GND-Nummer	1100314660
Datensatz-ID	1100314660
Beteiligt an alle anzeigen Präzisionsonkologie in Deutschland – transsektorale Vernetzung zum Wohl der Patient:innen TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration Weiterentwicklung und Vernetzung der onkologischen Versorgungsstrukturen, der Qualitätssicherung und der Forschung Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Kapazität der onkologischen Versorgung in deutschen onkologischen Spitzenzentren während der ersten 2 Jahre der COVID-19-Pandemie Organoids at the PUB: The Porcine Urinary Bladder Serves as a Pancreatic Niche for Advanced Cancer Modeling Arbeitsgruppen zu kolorektalen Tumoren der AIO, der ACO und der ARO – „past, present, and future“ S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL Leitlinienreport der S3-Leitlinie zum exokrinen Pankreaskarzinom : Version 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice Blood-Based Targeted Metabolomics Discriminate Patients with Alcoholic Liver Cirrhosis from Those with Non-Cirrhotic Liver Damage: An Explorative Study Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Functional genomic screening in human pluripotent stem cells reveals new roadblocks in early pancreatic endoderm formation Organoids at the PUB : the porcine urinary bladder serves as a pancreatic niche for advanced cancer modeling Tumor treating fields concomitant with sorafenib in advanced hepatocellular cancer: results of the HEPANOVA phase II study Tumor-treating fields concomitant with sorafenib in advanced hepatocellular cancer: results of the HEPANOVA Phase II Study A complex intervention to promote prevention of delirium in older adults by targeting caregiver’s participation during and after hospital discharge – study protocol of the TRAnsport and DElirium in older people (TRADE) project Systemic Therapy for Metastatic Pancreatic Cancer Which EORTC QLQ-C30 and -CR29 scores are relevant for clinicians for therapy planning and decisions? : Results of an online survey Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration Heidelberger Meilenstein Kommunikation (HeiMeKOM) – Erfahrungen, Best Practice Beispiele und Empfehlungen aus dem Abschluss-Symposium am 30./31. Januar 2020 CDKN2A-mutated pancreatic ductal organoids from induced pluripotent stem cells to model a cancer predisposition syndrome Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen = Diagnosis and therapy of tumors with NTRK gene fusion Functional genomic screening during somatic cell reprogramming identifies DKK3 as a roadblock of organ regeneration Systemic therapy for metastatic pancreatic cancer Targeting DNA damage repair mechanisms in pancreas cancer Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiation Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiation Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen Immunotherapy in Gastrointestinal Cancers Prevalence of Psychotropic Drugs in Cases of Severe Adverse Drug Reactions Leading to Unplanned Emergency Visits in General Hospitals Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper Adverse drug Rreactions in the Eemergency Ddepartment: is there a role for pharmacogenomic profiles at risk?-Results from the ADRED Study Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, Capecitabine, and Tegafur : a consensus paper Safety, efficacy and pharcacokinetics of targeted therapy with the liposomal RNA interference therapeutic Atu027 combined with Gemcitabine in patients with pancreatic adenocarcinoma. A randomized phase Ib/IIa study Personalising drug safety—results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED) Empfehlungen zur Früherkennung, Risikoreduktion, Überwachung und Therapie bei Patienten mit Lynch-Syndrom Molecular Approaches to Metastatic Colorectal Cancer: Better Diagnosis – Better Treatment? Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group ASCO- und ESMO-Update 2017 – Neuigkeiten vom 53. Meeting der American Society of Clinical Oncology/ASCO 2017 und European Society for Medical Oncology/ESMO-Congress 2017 Akute und chronische Bauchspeicheldrüsenentzündung Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group Population nutrikinetics of green tea extract CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society Aflibercept : eine effektive und verträgliche Option ab der zweiten mCRC-Therapielinie Reprogramming to pluripotency does not require transition through a primitive streak-like state Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society Onkologische Versorgung – was macht die Qualität aus und wie können wir diese erfassen? Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling Trans-sectoral care in patients with colorectal cancer: Protocol of the randomized controlled multi-center trial Supportive Cancer Care Networkers (SCAN) A Dynamic Role of TBX3 in the Pluripotency Circuitry Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study Pre-Study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis Adjuvante und palliative Therapie des Pankreaskarzinoms – Update Identification and characterization of Abelson Interactor 1, as a novel substrate of Protein Kinase D2

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Thomas Seufferlein (1963-)

Präzisionsonkologie in Deutschland – transsektorale Vernetzung zum Wohl der Patient:innen

TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration

Weiterentwicklung und Vernetzung der onkologischen Versorgungsstrukturen, der Qualitätssicherung und der Forschung

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Kapazität der onkologischen Versorgung in deutschen onkologischen Spitzenzentren während der ersten 2 Jahre der COVID-19-Pandemie

Organoids at the PUB: The Porcine Urinary Bladder Serves as a Pancreatic Niche for Advanced Cancer Modeling

Arbeitsgruppen zu kolorektalen Tumoren der AIO, der ACO und der ARO – „past, present, and future“

S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL

S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL

Leitlinienreport der S3-Leitlinie zum exokrinen Pankreaskarzinom : Version 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL

Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice

Blood-Based Targeted Metabolomics Discriminate Patients with Alcoholic Liver Cirrhosis from Those with Non-Cirrhotic Liver Damage: An Explorative Study

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Functional genomic screening in human pluripotent stem cells reveals new roadblocks in early pancreatic endoderm formation

Organoids at the PUB : the porcine urinary bladder serves as a pancreatic niche for advanced cancer modeling

Tumor treating fields concomitant with sorafenib in advanced hepatocellular cancer: results of the HEPANOVA phase II study

Tumor-treating fields concomitant with sorafenib in advanced hepatocellular cancer: results of the HEPANOVA Phase II Study

A complex intervention to promote prevention of delirium in older adults by targeting caregiver’s participation during and after hospital discharge – study protocol of the TRAnsport and DElirium in older people (TRADE) project

Systemic Therapy for Metastatic Pancreatic Cancer

Which EORTC QLQ-C30 and -CR29 scores are relevant for clinicians for therapy planning and decisions? : Results of an online survey

Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration

Heidelberger Meilenstein Kommunikation (HeiMeKOM) – Erfahrungen, Best Practice Beispiele und Empfehlungen aus dem Abschluss-Symposium am 30./31. Januar 2020

CDKN2A-mutated pancreatic ductal organoids from induced pluripotent stem cells to model a cancer predisposition syndrome

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen = Diagnosis and therapy of tumors with NTRK gene fusion

Functional genomic screening during somatic cell reprogramming identifies DKK3 as a roadblock of organ regeneration

Systemic therapy for metastatic pancreatic cancer

Targeting DNA damage repair mechanisms in pancreas cancer

Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiation

Transcriptional changes and the role of ONECUT1 in hPSC pancreatic differentiation

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen

Immunotherapy in Gastrointestinal Cancers

Prevalence of Psychotropic Drugs in Cases of Severe Adverse Drug Reactions Leading to Unplanned Emergency Visits in General Hospitals

Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper

Adverse drug Rreactions in the Eemergency Ddepartment: is there a role for pharmacogenomic profiles at risk?-Results from the ADRED Study

Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, Capecitabine, and Tegafur : a consensus paper

Safety, efficacy and pharcacokinetics of targeted therapy with the liposomal RNA interference therapeutic Atu027 combined with Gemcitabine in patients with pancreatic adenocarcinoma. A randomized phase Ib/IIa study

Personalising drug safety—results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED)

Empfehlungen zur Früherkennung, Risikoreduktion, Überwachung und Therapie bei Patienten mit Lynch-Syndrom

Molecular Approaches to Metastatic Colorectal Cancer: Better Diagnosis – Better Treatment?

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

ASCO- und ESMO-Update 2017 – Neuigkeiten vom 53. Meeting der American Society of Clinical Oncology/ASCO 2017 und European Society for Medical Oncology/ESMO-Congress 2017

Akute und chronische Bauchspeicheldrüsenentzündung

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

Population nutrikinetics of green tea extract

CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach

Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society

Aflibercept : eine effektive und verträgliche Option ab der zweiten mCRC-Therapielinie

Reprogramming to pluripotency does not require transition through a primitive streak-like state

Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society

Onkologische Versorgung – was macht die Qualität aus und wie können wir diese erfassen?

Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling

Trans-sectoral care in patients with colorectal cancer: Protocol of the randomized controlled multi-center trial Supportive Cancer Care Networkers (SCAN)

A Dynamic Role of TBX3 in the Pluripotency Circuitry

Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action

Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study

Pre-Study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis

Adjuvante und palliative Therapie des Pankreaskarzinoms – Update

Identification and characterization of Abelson Interactor 1, as a novel substrate of Protein Kinase D2